Profile Picture
  • All
  • Search
  • Images
  • Videos
  • Maps
  • News
  • Copilot
  • More
    • Shopping
    • Flights
    • Travel
  • Notebook
  • Top stories
  • Winter Games
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Business
  • More
    Politics
Order byBest matchMost fresh
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days

Agrees to review Moderna flu vaccine

Digest more
Top News
Overview
 · 15h · on MSN
Moderna says FDA to review its flu vaccine after reversing course
The U.S. Food and Drug Administration has reversed an earlier decision and said it will review drugmaker Moderna's application for approval of a seasonal flu vaccine, the company said in a statement W...

Continue reading

 · 16h
FDA to review Moderna's mRNA flu vaccine after initial rejection
 · 14h · on MSN
FDA plans review of Moderna flu vaccine for older adults
 · 19h
FDA reverses course and will review Moderna’s mRNA flu shot, company says
The US Food and Drug Administration has reversed course and will review a new mRNA flu vaccine from Moderna, the pharmaceutical company said Wednesday.

Continue reading

 · 19h
FDA reverses course, will review Moderna's mRNA flu vaccine
 · 19h
FDA Reverses Course and Will Now Review Moderna’s Flu Shot
Scientific American
17h

FDA agrees to review Moderna mRNA flu vaccine in dramatic reversal

After initially rejecting Moderna’s application for review, the FDA will now consider the company’s mRNA flu shot
21h

Health Rounds: Moderna combo flu/COVID vaccine succeeds in mid-stage trial

The study involved 550 healthy U.S. adults ages 18 to 75 who received either the experimental combo vaccine and a placebo or two separate shots of Moderna’s commercially available mRNA flu and COVID vaccines, according to a report published in Human Vaccines and Therapeutics.
Opinion
The Daily News
2d
Opinion

Moderna’s flu shot ordeal hurts innovation — and public health

The Food and Drug Administration’s recent decision to turn away Moderna’s application for a new flu shot for older Americans is a troubling development in health officials’ piecemeal dismantling of
  • Privacy
  • Terms